Atlas Trials

Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk

Clinical trial NCT02272946 · COMPLETED

Trial details

NCT number
NCT02272946
Sponsor
Priscilla Hsue, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIVCardiovascular Disease
Start date
2015-09-01
Primary completion
2021-02-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.